ARCHIVES

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

Smoking & Health Contractors Meet

July 11, 1975

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

Von Eschenbach Takes NCI’s Helm As Bush Proposes Budget Increase.

February 8, 2002

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991